My Account Log in

1 option

Long-Acting Injectable Medications in Mental Health / by Megan J. Ehret.

Springer Nature - Springer Medicine (R0) eBooks 2025 English International Available online

View online
Format:
Book
Author/Creator:
Ehret, Megan J.
Series:
Medicine Series
Language:
English
Subjects (All):
Pharmacy.
Psychiatry.
Pharmacovigilance.
Drug Safety and Pharmacovigilance.
Local Subjects:
Pharmacy.
Psychiatry.
Drug Safety and Pharmacovigilance.
Physical Description:
1 online resource (262 pages)
Edition:
1st ed. 2025.
Place of Publication:
Cham : Springer Nature Switzerland : Imprint: Springer, 2025.
Summary:
Long-Acting Injectable Medications in Mental Health describes the currently available long-acting injectable (LAI) medications to treat mental health and substance use disorders. Each chapter details how the medication's LAI technology utilized by the formulation, the dosing parameters, including missed dosing, pharmacokinetic properties, drug interactions, adverse effects, and preparation and administration instructions. Additionally, each medication chapter describes the efficacy of the formulation in comparison to other LAIs and oral medications. The book provides insight into how to approach a patient to engage in a conversation regarding LAI options. Switching strategies between agents and discontinuation options for patients are also included. Clinical pearls and tips on the role of these medications in clinical practice are provided to assist providers and pharmacists with the selection of agents and best practices regarding their use. A chapter is devoted to the use of LAIs in special populations (pregnant and lactating patients, older adults, pediatrics). The book is unique in that it encompasses all aspects of LAIs, from conversation to selection to administration and beyond. As this marketplace continues to increase, LAIs are becoming a mainstay of therapy for those with serious mental illness and substance use disorders. This book highlights the differences in products and the importance of understanding these differences to have the best outcome for the patient. Many providers are not familiar or comfortable with these formulations, but this book provides pharmacists and other healthcare providers, who are positioned to discuss these options with patients, with a highly accessible and comprehensive resource.
Contents:
Introduction
History of LAIs
Brief guidance on use of LAIs- where are the current guidelines
Evidence of Effectiveness
First Generation Antipsychotic LAIs
Haloperidol
Fluphenazine
Aripiprazole Products
Abilify Maintena
Abilify Asimtufii
Aristada (to include Initio)
Paliperidone
Invega Sustenna
Invega Trinza
Invega Hafyera
Risperidone
Risperdal Consta (to include information on generic availability)
Perseris
Uzedy
Rykindo
Olanzapine
Zyprexa Relprevv
Naltrexone
Vivitrol
Buprenorphine
Sublocade
Brixadi
Special Populations
Pediatrics
Older Adults
Pregnancy and Lactation
Approaching the Patient and Successful Utilization
Successful discussions
Clinic set-up
Pharmacist Administration
Future of LAIs
Discussion of future products and where practice is headed
Conclusion
Medication Reference Tables.
Notes:
Description based on publisher supplied metadata and other sources.
Other Format:
Print version: Ehret, Megan J. Long-Acting Injectable Medications in Mental Health
ISBN:
9783032094155
OCLC:
1568047385

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account